ASCO Connection

FEATURED BLOGS

Love of Learning in the Time of COVID-19

Apr 02, 2020

Dr. Martina Murphy, Dr. Devika Das, and Dr. Elizabeth Henry consider how the COVID-19 pandemic is affecting hematology/oncology training, and offer tips for staying connected to trainees.

An International Medical Graduate’s Journey in the COVID-19 Pandemic

International Perspectives

Apr 01, 2020

Dr. Mona Hassan arrived in the United States excited for professional development and activism opportunities. Within a week, COVID-19 completely derailed her plans.

Prostate Cancer, Androgen Deprivation Therapy, and COVID-19

L. Michael Glode, MD, FACP, FASCO

Apr 01, 2020

The TMPRSS2 protein has a role in both COVID-19 and in prostate cancer, suggesting intriguing avenues of inquiry for researchers engaged in the fight against COVID-19.

The Blind Leading the Blind: COVID-19, Cancer, and the Need for More Data

Gilberto Lopes, MD, MBA

Mar 25, 2020

My coauthors and I call on every oncology caregiver and stakeholder to join us in the fight against our lack of information and help us gather the data that will be paramount to guide our practices...

We Cannot Lose Another Oncologist to Burnout: Encouraging a Path Towards Wellness

Physician Wellness

Mar 24, 2020

Dr. Anna M. Laucis examines the drivers of professional burnout in oncology, and the devastating cost of failing to acknowledge the effects of burnout.

#OncoAlert Celebrates Its First Birthday Amidst COVID-19 Pandemic

Miriam Knoll, MD

Mar 23, 2020

Dr. Gil Morgan shares the story behind #OncoAlert, and we discuss why you should be paying attention, especially in our current situation.

Cancer Care in the Time of COVID-19

Matthew S. Katz, MD

Mar 23, 2020

We can work to limit the spread of COVID-19 while providing humane, evidence-based cancer care.

2 Comments

Resources for Oncologists Caring for Patients Affected by COVID-19

ASCO advises oncologists to use the best available evidence in caring for patients who may be exposed to or infected with the novel coronavirus (COVID-19), recognizing that evidence is both limited and evolving.